Leerink Swann downgrades Auxilium Pharmaceuticals (Nasdaq: AUXL) from Outperform to Market Perform. Price target lowered from $40 to $35.

Leerink ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE